AQUILON PHARMACEUTICALS

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte : STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), CAPITAL, ACTIONS",
      "value": "STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), CAPITAL, ACTIONS",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-08-10",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 10/08/2026 - Annexes du Moniteur belge",
      "value": "10/08/2026",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-08-06",
      "type": "filing",
      "quote": "D\u00E9pos\u00E9 06-08-2026",
      "value": "06-08-2026",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-08-06",
      "type": "notarial_deed",
      "quote": "D\u2019un acte re\u00E7u par Geoffrey GAUTHY, Notaire \u00E0 Herstal... en date du 6 ao\u00FBt 2026",
      "value": "6 ao\u00FBt 2026",
      "object": "e2",
      "subject": "e1"
    },
    {
      "date": "2026-08-06",
      "type": "general_meeting",
      "quote": "s\u0027est r\u00E9unie l\u0027Assembl\u00E9e G\u00E9n\u00E9rale Extraordinaire des actionnaires... en date du 6 ao\u00FBt 2026",
      "value": "6 ao\u00FBt 2026",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "share_issue",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide d\u2019\u00E9mettre 3.000 droits de souscription donnant chacun droit \u00E0 la souscription d\u2019une (1) action... au prix de 75 \u20AC par action nouvelle.",
      "value": {
        "count": 3000,
        "price": "75 \u20AC",
        "details": "nominatifs, incessibles, dur\u00E9e 5 ans",
        "instrument": "droits de souscription"
      },
      "object": null,
      "subject": "e1"
    },
    {
      "type": "capital_increase",
      "quote": "l\u2019assembl\u00E9e d\u00E9cide d\u2019augmenter le capital... \u00E0 concurrence de 225.000,00 \u20AC maximum, par la cr\u00E9ation de 3.000 actions maximum \u00E0 souscrire et \u00E0 lib\u00E9rer int\u00E9gralement en esp\u00E8ces",
      "value": {
        "type": "cash",
        "currency": "EUR",
        "condition": "suspensive de l\u2019exercice de tout ou partie des droits de souscription",
        "max_amount": 225000.0,
        "shares_max": 3000
      },
      "object": null,
      "subject": "e1"
    },
    {
      "type": "capital_increase",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide d\u2019augmenter le capital \u00E0 concurrence de 412.884,00 \u20AC pour le porter de 5.486.277,23 \u20AC \u00E0 5.899.161,23 \u20AC par l\u2019\u00E9mission de 7.972 actions nouvelles... \u00E0 lib\u00E9rer imm\u00E9diatement... par l\u2019apport de cr\u00E9ances",
      "value": {
        "type": "in_kind",
        "after": 5899161.23,
        "amount": 412884.0,
        "before": 5486277.23,
        "shares": 7972,
        "currency": "EUR",
        "contribution": "apport de cr\u00E9ances",
        "share_classes": {
          "A": 1574,
          "C": 209,
          "D": 6189
        }
      },
      "amount": 412884.0,
      "object": null,
      "subject": "e1",
      "currency": "EUR"
    },
    {
      "type": "capital",
      "quote": "Le capital est fix\u00E9 \u00E0 cinq millions huit cent nonante-neuf mille cent soixante et un euros vingt-trois cents (5.899.161,23 \u20AC). Il est repr\u00E9sent\u00E9 par 270.646 actions... dont 44.994 actions de classe A, 70.616 actions de classe B, 42.623 actions de classe C, 103.400 actions de classe D, et 9.013 actions de classe E.",
      "value": {
        "amount": 5899161.23,
        "shares": 270646,
        "classes": {
          "A": 44994,
          "B": 70616,
          "C": 42623,
          "D": 103400,
          "E": 9013
        },
        "currency": "EUR"
      },
      "amount": 5899161.23,
      "object": null,
      "subject": "e1",
      "currency": "EUR"
    },
    {
      "type": "statute_amendment",
      "quote": "l\u2019assembl\u00E9e d\u00E9cide de modifier l\u2019article 5 \u00A71er des statuts par le remplacement du texte actuel par le texte suivant",
      "value": "modification de l\u0027article 5 \u00A71er des statuts",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "preemptive_rights_waiver",
      "quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de supprimer le droit de pr\u00E9f\u00E9rence conf\u00E9r\u00E9 aux actionnaires par la loi et par les statuts conform\u00E9ment \u00E0 l\u2019article 7:191 du Code des Soci\u00E9t\u00E9s et des Associations, au profit des futurs b\u00E9n\u00E9ficiaires d\u00E9sign\u00E9s par le Conseil d\u0027administration.",
      "value": "Suppression du droit de pr\u00E9f\u00E9rence pour l\u0027\u00E9mission de droits de souscription",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "power_delegation",
      "quote": "Suite aux d\u00E9clarations qui pr\u00E9c\u00E8dent, l\u0027assembl\u00E9e conf\u00E8re tout pouvoir au Conseil d\u2019administration de la soci\u00E9t\u00E9 pour d\u00E9signer les b\u00E9n\u00E9ficiaires des 3.000 droits de souscription parmi les administrateurs actifs, membres du personnel et/ou consultants de la Soci\u00E9t\u00E9 dans la gestion et le d\u00E9veloppement de celle-ci, pour d\u00E9terminer le nombre exact de droits de souscription accord\u00E9 \u00E0 chaque b\u00E9n\u00E9ficiaire et le moment de l\u2019attribution effective. L\u0027assembl\u00E9e conf\u00E8re au Conseil d\u2019administration tous pouvoirs n\u00E9cessaires pour l\u0027ex\u00E9cution des r\u00E9solutions qui pr\u00E9c\u00E8dent...",
      "value": "D\u00E9l\u00E9gation de pouvoirs au Conseil d\u0027administration pour d\u00E9signer les b\u00E9n\u00E9ficiaires des droits de souscription et ex\u00E9cuter les r\u00E9solutions",
      "object": null,
      "subject": "e1"
    }
  ],
  "act_meta": {
    "outcome": "corrected",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 16668,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0540.870.218",
      "kind": "company",
      "name": "AQUILON PHARMACEUTICALS",
      "attrs": {
        "seat": "Rue du Bois St-Jean 15/1, 4102 Seraing",
        "legal_form": "Soci\u00E9t\u00E9 anonyme"
      }
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "person",
      "name": "Geoffrey GAUTHY",
      "attrs": {
        "firm": "Neonotaires",
        "role": "Notaire",
        "address": "Herstal"
      }
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "org",
      "name": "Neonotaires",
      "attrs": {
        "seat": "Herstal",
        "type": "Soci\u00E9t\u00E9 notariale"
      }
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "org",
      "name": "AXYLIUM",
      "attrs": {
        "type": "Soci\u00E9t\u00E9 de r\u00E9vision"
      }
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "person",
      "name": "DEMONCEAU David",
      "attrs": {
        "role": "r\u00E9viseur d\u2019entreprises",
        "employer": "AXYLIUM"
      }
    }
  ]
}

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte : CONSTITUTION",
      "value": "CONSTITUTION",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-07-20",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 20/07/2026 - Annexes du Moniteur belge",
      "value": "20/07/2026",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-07-16",
      "type": "filing",
      "quote": "D\u00E9pos\u00E9 16-07-2026",
      "value": "16-07-2026",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-07-16",
      "type": "notarial_deed",
      "quote": "D\u2019un acte re\u00E7u par Ma\u00EEtre Geoffrey GAUTHY, Notaire \u00E0 Herstal... en date du 16 juillet 2026",
      "value": "16 juillet 2026",
      "object": "e3",
      "subject": "e1"
    },
    {
      "date": "2026-07-16",
      "type": "incorporation",
      "quote": "Le comparant d\u00E9clare constituer une soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e sous la d\u00E9nomination \u00AB ALIZES PHARMA \u00BB.",
      "value": "16 juillet 2026",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "founder",
      "quote": "La soci\u00E9t\u00E9 anonyme \u00AB AQUILON PHARMACEUTICALS \u00BB... A constitu\u00E9 une soci\u00E9t\u00E9 ainsi qu\u2019il suit :",
      "value": null,
      "object": "e1",
      "subject": "e2"
    },
    {
      "type": "founding_capital",
      "quote": "Le patrimoine de la soci\u00E9t\u00E9 est repr\u00E9sent\u00E9 par 1.000 actions... Le comparant d\u00E9clare souscrire aux 1.000 actions et lib\u00E9rer imm\u00E9diatement sa souscription pour la totalit\u00E9 par un apport en num\u00E9raire de quinze mille euros (15.000,00 \u20AC).",
      "value": {
        "amount": 15000.0,
        "shares": 1000,
        "currency": "EUR",
        "subscribers": [
          "e2"
        ]
      },
      "amount": 15000.0,
      "object": null,
      "subject": "e1",
      "currency": "EUR"
    },
    {
      "type": "purpose",
      "quote": "Article 3 Objet La soci\u00E9t\u00E9 a pour objet...",
      "value": "la recherche, le d\u00E9veloppement, la formulation, la caract\u00E9risation, la mise au point, la production et la valorisation de solutions th\u00E9rapeutiques destin\u00E9es \u00E0 l\u0027administration, sous forme de poudre s\u00E8che, par voie inhal\u00E9e et/ou nasale, de mol\u00E9cules biologiques \u2014 notamment peptides, prot\u00E9ines et anticorps \u2014 \u00E0 vis\u00E9e th\u00E9rapeutique syst\u00E9mique et/ou locale, en ce compris les technologies de formulation et de d\u00E9livrance y aff\u00E9rentes ; l\u0027acquisition, la d\u00E9tention, la gestion, le d\u00E9veloppement, l\u0027exploitation, la concession ainsi que la prise et l\u0027octroi de licences de tous droits de propri\u00E9t\u00E9 intellectuelle (brevets, demandes de brevets, savoir-faire, marques, donn\u00E9es de d\u00E9veloppement) relatifs \u00E0 ces applications et technologies ; la conclusion et l\u0027ex\u00E9cution de tout contrat de licence, de partenariat, de co-d\u00E9veloppement, de fabrication, de fourniture, de distribution ou de commercialisation portant sur lesdits produits et technologies ; la prestation de services de conseil et d\u0027expertise dans ces domaines. Elle pourra s\u0027int\u00E9resser par voie d\u0027association, d\u0027apport, de fusion, de souscription, d\u0027intervention financi\u00E8re ou autrement, dans toutes soci\u00E9t\u00E9s, associations ou entreprises dont l\u0027objet est identique, analogue ou connexe au sien, ou de nature \u00E0 favoriser le d\u00E9veloppement de son entreprise ou \u00E0 constituer pour elle une source de d\u00E9bouch\u00E9s. Elle peut accomplir toutes op\u00E9rations g\u00E9n\u00E9ralement quelconques, commerciales, industrielles, financi\u00E8res, mobili\u00E8res ou immobili\u00E8res, se rapportant directement ou indirectement \u00E0 son objet.",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "first_fiscal_year",
      "quote": "Le premier exercice commencera le jour de la constitution de la soci\u00E9t\u00E9 pour se terminer le 31 d\u00E9cembre 2027.",
      "value": {
        "end": "31 d\u00E9cembre 2027",
        "start": "16 juillet 2026"
      },
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-07-16",
      "type": "officer_appointment",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de nommer comme administrateurs ordinaires, pour une dur\u00E9e ind\u00E9termin\u00E9e : \u2022 La soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB MAES PHARMCONSULT \u00BB...",
      "value": {
        "role": "administrateur",
        "term": "dur\u00E9e ind\u00E9termin\u00E9e",
        "start_date": "2026-07-16"
      },
      "object": "e1",
      "subject": "e4",
      "_value_raw": {
        "role": "administrateur",
        "term": "dur\u00E9e ind\u00E9termin\u00E9e",
        "start_date": "16 juillet 2026"
      }
    },
    {
      "type": "permanent_representative",
      "quote": "...dont le repr\u00E9sentant permanent sera Monsieur MAES Paul...",
      "value": null,
      "object": "e4",
      "subject": "e5"
    },
    {
      "date": "2026-07-16",
      "type": "officer_appointment",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de nommer comme administrateurs ordinaires, pour une dur\u00E9e ind\u00E9termin\u00E9e : ... \u2022 La soci\u00E9t\u00E9 \u00AB MILEGRAND \u00BB...",
      "value": {
        "role": "administrateur",
        "term": "dur\u00E9e ind\u00E9termin\u00E9e",
        "start_date": "2026-07-16"
      },
      "object": "e1",
      "subject": "e6",
      "_value_raw": {
        "role": "administrateur",
        "term": "dur\u00E9e ind\u00E9termin\u00E9e",
        "start_date": "16 juillet 2026"
      }
    },
    {
      "type": "permanent_representative",
      "quote": "...dont le repr\u00E9sentant permanent sera Monsieur LEGRAND Micha\u00EBl Philippe Michel...",
      "value": null,
      "object": "e6",
      "subject": "e7"
    },
    {
      "date": "2026-07-16",
      "type": "officer_appointment",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de nommer comme administrateurs ordinaires, pour une dur\u00E9e ind\u00E9termin\u00E9e : ... \u2022 Monsieur CATALDO Didier Daniel Claude Philippe...",
      "value": {
        "role": "administrateur",
        "term": "dur\u00E9e ind\u00E9termin\u00E9e",
        "start_date": "2026-07-16"
      },
      "object": "e1",
      "subject": "e8",
      "_value_raw": {
        "role": "administrateur",
        "term": "dur\u00E9e ind\u00E9termin\u00E9e",
        "start_date": "16 juillet 2026"
      }
    },
    {
      "date": "2026-07-16",
      "type": "officer_appointment",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de nommer comme administrateurs ordinaires, pour une dur\u00E9e ind\u00E9termin\u00E9e : ... \u2022 Monsieur NELLES Charles Henri Alex...",
      "value": {
        "role": "administrateur",
        "term": "dur\u00E9e ind\u00E9termin\u00E9e",
        "start_date": "2026-07-16"
      },
      "object": "e1",
      "subject": "e9",
      "_value_raw": {
        "role": "administrateur",
        "term": "dur\u00E9e ind\u00E9termin\u00E9e",
        "start_date": "16 juillet 2026"
      }
    },
    {
      "date": "2026-07-16",
      "type": "officer_appointment",
      "quote": "Les administrateurs ci-dessus nomm\u00E9s, r\u00E9unis en Coll\u00E8ge d\u2019administrateurs et statuant \u00E0 l\u0027unanimit\u00E9 d\u00E9signent comme pr\u00E9sident du Coll\u00E8ge la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB MAES PHARMCONSULT \u00BB...",
      "value": {
        "role": "Pr\u00E9sident du Coll\u00E8ge d\u2019administrateurs",
        "start_date": "2026-07-16"
      },
      "object": "e1",
      "subject": "e4",
      "_value_raw": {
        "role": "Pr\u00E9sident du Coll\u00E8ge d\u2019administrateurs",
        "start_date": "16 juillet 2026"
      }
    },
    {
      "date": "2026-07-16",
      "type": "officer_appointment",
      "quote": "Conform\u00E9ment aux statuts, le Coll\u00E8ge d\u2019administrateurs d\u00E9cide \u00E0 l\u0027unanimit\u00E9 de d\u00E9l\u00E9guer la gestion journali\u00E8re de la soci\u00E9t\u00E9 ainsi que la repr\u00E9sentation de la soci\u00E9t\u00E9 en ce qui concerne cette gestion \u00E0 la soci\u00E9t\u00E9 \u00AB MILEGRAND \u00BB... Elle portera le titre d\u0027administrateur-d\u00E9l\u00E9gu\u00E9.",
      "value": {
        "role": "administrateur-d\u00E9l\u00E9gu\u00E9",
        "start_date": "2026-07-16"
      },
      "object": "e1",
      "subject": "e6",
      "_value_raw": {
        "role": "administrateur-d\u00E9l\u00E9gu\u00E9",
        "start_date": "16 juillet 2026"
      }
    },
    {
      "type": "filing_representative",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de nommer chaque administrateur afin de disposer des fonds et afin de proc\u00E9der aux formalit\u00E9s requises...",
      "value": "disposer des fonds et proc\u00E9der aux formalit\u00E9s requises pour l\u0027inscription de la soci\u00E9t\u00E9 \u00E0 la Banque Carrefour des Entreprises, \u00E0 la T.V.A. et \u00E0 l\u0027O.N.S.S., et en g\u00E9n\u00E9ral toutes formalit\u00E9s n\u00E9cessaires ou utiles permettant \u00E0 la soci\u00E9t\u00E9 d\u0027entamer ses activit\u00E9s, avec pouvoir de subd\u00E9l\u00E9gation",
      "object": "e1",
      "subject": "e4"
    },
    {
      "type": "filing_representative",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de nommer chaque administrateur afin de disposer des fonds et afin de proc\u00E9der aux formalit\u00E9s requises...",
      "value": "disposer des fonds et proc\u00E9der aux formalit\u00E9s requises pour l\u0027inscription de la soci\u00E9t\u00E9 \u00E0 la Banque Carrefour des Entreprises, \u00E0 la T.V.A. et \u00E0 l\u0027O.N.S.S., et en g\u00E9n\u00E9ral toutes formalit\u00E9s n\u00E9cessaires ou utiles permettant \u00E0 la soci\u00E9t\u00E9 d\u0027entamer ses activit\u00E9s, avec pouvoir de subd\u00E9l\u00E9gation",
      "object": "e1",
      "subject": "e6"
    },
    {
      "type": "filing_representative",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de nommer chaque administrateur afin de disposer des fonds et afin de proc\u00E9der aux formalit\u00E9s requises...",
      "value": "disposer des fonds et proc\u00E9der aux formalit\u00E9s requises pour l\u0027inscription de la soci\u00E9t\u00E9 \u00E0 la Banque Carrefour des Entreprises, \u00E0 la T.V.A. et \u00E0 l\u0027O.N.S.S., et en g\u00E9n\u00E9ral toutes formalit\u00E9s n\u00E9cessaires ou utiles permettant \u00E0 la soci\u00E9t\u00E9 d\u0027entamer ses activit\u00E9s, avec pouvoir de subd\u00E9l\u00E9gation",
      "object": "e1",
      "subject": "e8"
    },
    {
      "type": "filing_representative",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de nommer chaque administrateur afin de disposer des fonds et afin de proc\u00E9der aux formalit\u00E9s requises...",
      "value": "disposer des fonds et proc\u00E9der aux formalit\u00E9s requises pour l\u0027inscription de la soci\u00E9t\u00E9 \u00E0 la Banque Carrefour des Entreprises, \u00E0 la T.V.A. et \u00E0 l\u0027O.N.S.S., et en g\u00E9n\u00E9ral toutes formalit\u00E9s n\u00E9cessaires ou utiles permettant \u00E0 la soci\u00E9t\u00E9 d\u0027entamer ses activit\u00E9s, avec pouvoir de subd\u00E9l\u00E9gation",
      "object": "e1",
      "subject": "e9"
    },
    {
      "type": "mandate_compensation",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide que le mandat d\u2019administrateur sera exerc\u00E9 gratuitement jusqu\u2019\u00E0 d\u00E9cision contraire de l\u2019assembl\u00E9e.",
      "value": "gratuit",
      "object": "e1",
      "subject": "e4"
    },
    {
      "type": "mandate_compensation",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide que le mandat d\u2019administrateur sera exerc\u00E9 gratuitement jusqu\u2019\u00E0 d\u00E9cision contraire de l\u2019assembl\u00E9e.",
      "value": "gratuit",
      "object": "e1",
      "subject": "e6"
    },
    {
      "type": "mandate_compensation",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide que le mandat d\u2019administrateur sera exerc\u00E9 gratuitement jusqu\u2019\u00E0 d\u00E9cision contraire de l\u2019assembl\u00E9e.",
      "value": "gratuit",
      "object": "e1",
      "subject": "e8"
    },
    {
      "type": "mandate_compensation",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide que le mandat d\u2019administrateur sera exerc\u00E9 gratuitement jusqu\u2019\u00E0 d\u00E9cision contraire de l\u2019assembl\u00E9e.",
      "value": "gratuit",
      "object": "e1",
      "subject": "e9"
    }
  ],
  "act_meta": {
    "outcome": "corrected",
    "postfix": [
      "primary company kbo missing -\u003E register 1040.385.871"
    ],
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 34053,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "1040.385.871",
      "kind": "company",
      "name": "ALIZES PHARMA",
      "attrs": {
        "seat": "Rue du Bois Saint-Jean 15/1, 4102 Seraing",
        "kbo_source": "register",
        "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
      }
    },
    {
      "id": "e2",
      "kbo": "0540.870.218",
      "kind": "company",
      "name": "AQUILON PHARMACEUTICALS",
      "attrs": {
        "seat": "4102 Seraing, rue du Bois Saint-Jean, 15/1",
        "legal_form": "Soci\u00E9t\u00E9 anonyme"
      }
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "Geoffrey GAUTHY",
      "attrs": {
        "role": "Notaire"
      }
    },
    {
      "id": "e4",
      "kbo": "0875.845.464",
      "kind": "company",
      "name": "MAES PHARMCONSULT",
      "attrs": {
        "seat": "4600 Vis\u00E9, rue de Dalhem, 5",
        "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
      }
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "person",
      "name": "MAES Paul",
      "attrs": {
        "address": "4600 Vis\u00E9, rue de Dalhem, 5"
      }
    },
    {
      "id": "e6",
      "kbo": "0649.598.409",
      "kind": "company",
      "name": "MILEGRAND",
      "attrs": {
        "seat": "5002 Namur, rue du Tivoli, 16"
      }
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "person",
      "name": "LEGRAND Micha\u00EBl Philippe Michel",
      "attrs": {
        "address": "5002 Saint-Servais, rue du Tivoli, 16"
      }
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "person",
      "name": "CATALDO Didier Daniel Claude Philippe",
      "attrs": {
        "address": "4877 Olne, chemin du Vieux Puits, 4"
      }
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "NELLES Charles Henri Alex",
      "attrs": {
        "address": "4960 Malmedy (Xhoffraix), Au-Dessus des Trous, 2"
      }
    }
  ]
}

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte : CONSTITUTION",
      "value": "CONSTITUTION",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-07-20",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 20/07/2026 - Annexes du Moniteur belge",
      "value": "20/07/2026",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-07-16",
      "type": "filing",
      "quote": "D\u00E9pos\u00E9 16-07-2026",
      "value": "16-07-2026",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-07-16",
      "type": "notarial_deed",
      "quote": "D\u2019un acte re\u00E7u par Ma\u00EEtre Geoffrey GAUTHY, Notaire \u00E0 Herstal... en date du 16 juillet 2026",
      "value": "16 juillet 2026",
      "object": "e3",
      "subject": "e1"
    },
    {
      "date": "2026-07-16",
      "type": "incorporation",
      "quote": "Le comparant d\u00E9clare constituer une soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e sous la d\u00E9nomination \u00AB AQUITEC PHARMA \u00BB.",
      "value": "16 juillet 2026",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "founder",
      "quote": "La soci\u00E9t\u00E9 anonyme \u00AB AQUILON PHARMACEUTICALS \u00BB... A constitu\u00E9 une soci\u00E9t\u00E9 ainsi qu\u2019il suit :",
      "value": null,
      "object": "e1",
      "subject": "e2"
    },
    {
      "type": "founding_capital",
      "quote": "Le patrimoine de la soci\u00E9t\u00E9 est repr\u00E9sent\u00E9 par 1.000 actions... Le comparant d\u00E9clare souscrire aux 1.000 actions et lib\u00E9rer imm\u00E9diatement sa souscription pour la totalit\u00E9 par un apport en num\u00E9raire de vingt mille euros (20.000,00 \u20AC).",
      "value": {
        "amount": 20000.0,
        "shares": 1000,
        "currency": "EUR",
        "subscribers": [
          "e2"
        ]
      },
      "amount": 20000.0,
      "object": null,
      "subject": "e1",
      "currency": "EUR",
      "_value_raw": {
        "amount": "20.000,00",
        "shares": 1000,
        "currency": "EUR",
        "subscribers": [
          "e2"
        ]
      }
    },
    {
      "type": "purpose",
      "quote": "Article 3 Objet... La soci\u00E9t\u00E9 a pour objet, en Belgique et \u00E0 l\u0027\u00E9tranger...",
      "value": "la recherche, le d\u00E9veloppement, la formulation, la mise au point, la fabrication, la production, l\u0027utilisation, la vente, l\u0027importation, l\u0027exportation, la distribution et la consultance relatives \u00E0 des solutions th\u00E9rapeutiques, m\u00E9dicamenteuses et/ou \u00E0 des dispositifs m\u00E9dicaux destin\u00E9s \u00E0 la voie nasale, en ce compris les technologies de formulation et de d\u00E9livrance nasale, les corticost\u00E9ro\u00EFdes nasaux, les formulations sans conservateur et leurs combinaisons ; l\u0027acquisition, la d\u00E9tention, la gestion, le d\u00E9veloppement, l\u0027exploitation, la concession ainsi que la prise et l\u0027octroi de licences de tous droits de propri\u00E9t\u00E9 intellectuelle (brevets, demandes de brevets, savoir-faire, marques, donn\u00E9es de d\u00E9veloppement) relatifs aux applications nasales ; la conclusion et l\u0027ex\u00E9cution de tout contrat de licence, de partenariat, de d\u00E9veloppement, de fabrication, de fourniture, de distribution ou de commercialisation portant sur lesdits produits et technologies nasaux. Elle pourra s\u0027int\u00E9resser par voie d\u0027association, d\u0027apport, de fusion, de souscription, d\u0027intervention financi\u00E8re ou autrement, dans toutes soci\u00E9t\u00E9s, associations ou entreprises dont l\u0027objet est identique, analogue ou connexe au sien, ou de nature \u00E0 favoriser le d\u00E9veloppement de son entreprise ou \u00E0 constituer pour elle une source de d\u00E9bouch\u00E9s. Elle peut accomplir toutes op\u00E9rations g\u00E9n\u00E9ralement quelconques, commerciales, industrielles, financi\u00E8res, mobili\u00E8res ou immobili\u00E8res, se rapportant directement ou indirectement \u00E0 son objet.",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-07-16",
      "type": "officer_appointment",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de nommer comme administrateurs ordinaires, pour une dur\u00E9e ind\u00E9termin\u00E9e : \u2022 La soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB MAES PHARMCONSULT \u00BB...",
      "value": {
        "role": "administrateur",
        "term": "dur\u00E9e ind\u00E9termin\u00E9e",
        "start_date": "2026-07-16"
      },
      "object": null,
      "subject": "e4",
      "_value_raw": {
        "role": "administrateur",
        "term": "dur\u00E9e ind\u00E9termin\u00E9e",
        "start_date": "16 juillet 2026"
      }
    },
    {
      "date": "2026-07-16",
      "type": "officer_appointment",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de nommer comme administrateurs ordinaires, pour une dur\u00E9e ind\u00E9termin\u00E9e : \u2022 La soci\u00E9t\u00E9 \u00AB MILEGRAND \u00BB...",
      "value": {
        "role": "administrateur",
        "term": "dur\u00E9e ind\u00E9termin\u00E9e",
        "start_date": "2026-07-16"
      },
      "object": null,
      "subject": "e6",
      "_value_raw": {
        "role": "administrateur",
        "term": "dur\u00E9e ind\u00E9termin\u00E9e",
        "start_date": "16 juillet 2026"
      }
    },
    {
      "date": "2026-07-16",
      "type": "officer_appointment",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de nommer comme administrateurs ordinaires, pour une dur\u00E9e ind\u00E9termin\u00E9e : \u2022 Monsieur CATALDO Didier Daniel Claude Philippe...",
      "value": {
        "role": "administrateur",
        "term": "dur\u00E9e ind\u00E9termin\u00E9e",
        "start_date": "2026-07-16"
      },
      "object": null,
      "subject": "e8",
      "_value_raw": {
        "role": "administrateur",
        "term": "dur\u00E9e ind\u00E9termin\u00E9e",
        "start_date": "16 juillet 2026"
      }
    },
    {
      "date": "2026-07-16",
      "type": "officer_appointment",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de nommer comme administrateurs ordinaires, pour une dur\u00E9e ind\u00E9termin\u00E9e : \u2022 Monsieur NELLES Charles Henri Alex...",
      "value": {
        "role": "administrateur",
        "term": "dur\u00E9e ind\u00E9termin\u00E9e",
        "start_date": "2026-07-16"
      },
      "object": null,
      "subject": "e9",
      "_value_raw": {
        "role": "administrateur",
        "term": "dur\u00E9e ind\u00E9termin\u00E9e",
        "start_date": "16 juillet 2026"
      }
    },
    {
      "type": "permanent_representative",
      "quote": "dont le repr\u00E9sentant permanent sera Monsieur MAES Paul",
      "value": null,
      "object": "e4",
      "subject": "e5"
    },
    {
      "type": "permanent_representative",
      "quote": "dont le repr\u00E9sentant permanent sera Monsieur LEGRAND Micha\u00EBl Philippe Michel",
      "value": null,
      "object": "e6",
      "subject": "e7"
    },
    {
      "date": "2026-07-16",
      "type": "officer_appointment",
      "quote": "Les administrateurs ci-dessus nomm\u00E9s, r\u00E9unis en Coll\u00E8ge d\u2019administrateurs et statuant \u00E0 l\u0027unanimit\u00E9 d\u00E9signent comme pr\u00E9sident du Coll\u00E8ge la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB MAES PHARMCONSULT \u00BB",
      "value": {
        "role": "pr\u00E9sident du Coll\u00E8ge d\u2019administrateurs",
        "start_date": "2026-07-16"
      },
      "object": null,
      "subject": "e4",
      "_value_raw": {
        "role": "pr\u00E9sident du Coll\u00E8ge d\u2019administrateurs",
        "start_date": "16 juillet 2026"
      }
    },
    {
      "date": "2026-07-16",
      "type": "officer_appointment",
      "quote": "le Coll\u00E8ge d\u2019administrateurs d\u00E9cide \u00E0 l\u0027unanimit\u00E9 de d\u00E9l\u00E9guer la gestion journali\u00E8re de la soci\u00E9t\u00E9 ainsi que la repr\u00E9sentation de la soci\u00E9t\u00E9 en ce qui concerne cette gestion \u00E0 la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB MAES PHARMCONSULT \u00BB... Elle portera le titre d\u0027administrateur-d\u00E9l\u00E9gu\u00E9.",
      "value": {
        "role": "administrateur-d\u00E9l\u00E9gu\u00E9",
        "start_date": "2026-07-16"
      },
      "object": null,
      "subject": "e4",
      "_value_raw": {
        "role": "administrateur-d\u00E9l\u00E9gu\u00E9",
        "start_date": "16 juillet 2026"
      }
    },
    {
      "type": "mandate_compensation",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide que le mandat d\u2019administrateur sera exerc\u00E9 gratuitement jusqu\u2019\u00E0 d\u00E9cision contraire de l\u2019assembl\u00E9e.",
      "value": "gratuit",
      "object": null,
      "subject": "e4"
    },
    {
      "type": "power_of_attorney",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de nommer chaque administrateur afin de disposer des fonds et afin de proc\u00E9der aux formalit\u00E9s requises...",
      "value": "disposer des fonds et proc\u00E9der aux formalit\u00E9s requises pour l\u0027inscription de la soci\u00E9t\u00E9 \u00E0 la Banque Carrefour des Entreprises, \u00E0 la T.V.A. et \u00E0 l\u0027O.N.S.S., et en g\u00E9n\u00E9ral toutes formalit\u00E9s n\u00E9cessaires ou utiles permettant \u00E0 la soci\u00E9t\u00E9 d\u0027entamer ses activit\u00E9s, avec pouvoir de subd\u00E9l\u00E9gation",
      "object": "e1",
      "subject": "e4"
    },
    {
      "type": "power_of_attorney",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de nommer chaque administrateur afin de disposer des fonds et afin de proc\u00E9der aux formalit\u00E9s requises...",
      "value": "disposer des fonds et proc\u00E9der aux formalit\u00E9s requises pour l\u0027inscription de la soci\u00E9t\u00E9 \u00E0 la Banque Carrefour des Entreprises, \u00E0 la T.V.A. et \u00E0 l\u0027O.N.S.S., et en g\u00E9n\u00E9ral toutes formalit\u00E9s n\u00E9cessaires ou utiles permettant \u00E0 la soci\u00E9t\u00E9 d\u0027entamer ses activit\u00E9s, avec pouvoir de subd\u00E9l\u00E9gation",
      "object": "e1",
      "subject": "e6"
    },
    {
      "type": "power_of_attorney",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de nommer chaque administrateur afin de disposer des fonds et afin de proc\u00E9der aux formalit\u00E9s requises...",
      "value": "disposer des fonds et proc\u00E9der aux formalit\u00E9s requises pour l\u0027inscription de la soci\u00E9t\u00E9 \u00E0 la Banque Carrefour des Entreprises, \u00E0 la T.V.A. et \u00E0 l\u0027O.N.S.S., et en g\u00E9n\u00E9ral toutes formalit\u00E9s n\u00E9cessaires ou utiles permettant \u00E0 la soci\u00E9t\u00E9 d\u0027entamer ses activit\u00E9s, avec pouvoir de subd\u00E9l\u00E9gation",
      "object": "e1",
      "subject": "e8"
    },
    {
      "type": "power_of_attorney",
      "quote": "L\u2019assembl\u00E9e d\u00E9cide de nommer chaque administrateur afin de disposer des fonds et afin de proc\u00E9der aux formalit\u00E9s requises...",
      "value": "disposer des fonds et proc\u00E9der aux formalit\u00E9s requises pour l\u0027inscription de la soci\u00E9t\u00E9 \u00E0 la Banque Carrefour des Entreprises, \u00E0 la T.V.A. et \u00E0 l\u0027O.N.S.S., et en g\u00E9n\u00E9ral toutes formalit\u00E9s n\u00E9cessaires ou utiles permettant \u00E0 la soci\u00E9t\u00E9 d\u0027entamer ses activit\u00E9s, avec pouvoir de subd\u00E9l\u00E9gation",
      "object": "e1",
      "subject": "e9"
    },
    {
      "type": "first_fiscal_year",
      "quote": "Le premier exercice commencera le jour de la constitution de la soci\u00E9t\u00E9 pour se terminer le 31 d\u00E9cembre 2027.",
      "value": {
        "end": "31 d\u00E9cembre 2027",
        "start": "16 juillet 2026"
      },
      "object": null,
      "subject": "e1"
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "postfix": [
      "primary company kbo missing -\u003E register 1040.385.970"
    ],
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 34032,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "1040.385.970",
      "kind": "company",
      "name": "AQUITEC PHARMA",
      "attrs": {
        "seat": "Rue du Bois Saint-Jean 15/1, 4102 Seraing",
        "kbo_source": "register",
        "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
      }
    },
    {
      "id": "e2",
      "kbo": "0540.870.218",
      "kind": "company",
      "name": "AQUILON PHARMACEUTICALS",
      "attrs": {
        "seat": "4102 Seraing, rue du Bois Saint-Jean, 15/1",
        "legal_form": "Soci\u00E9t\u00E9 anonyme"
      }
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "Geoffrey GAUTHY",
      "attrs": {
        "role": "Notaire"
      }
    },
    {
      "id": "e4",
      "kbo": "0875.845.464",
      "kind": "company",
      "name": "MAES PHARMCONSULT",
      "attrs": {
        "seat": "4600 Vis\u00E9, rue de Dalhem, 5",
        "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
      }
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "person",
      "name": "MAES Paul",
      "attrs": {
        "address": "4600 Vis\u00E9, rue de Dalhem, 5"
      }
    },
    {
      "id": "e6",
      "kbo": "0649.598.409",
      "kind": "company",
      "name": "MILEGRAND",
      "attrs": {
        "seat": "5002 Namur, rue du Tivoli, 16"
      }
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "person",
      "name": "LEGRAND Micha\u00EBl Philippe Michel",
      "attrs": {
        "address": "5002 Saint-Servais, rue du Tivoli, 16"
      }
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "person",
      "name": "CATALDO Didier Daniel Claude Philippe",
      "attrs": {
        "address": "4877 Olne, chemin du Vieux Puits, 4"
      }
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "NELLES Charles Henri Alex",
      "attrs": {
        "address": "4960 Malmedy (Xhoffraix), Au-Dessus des Trous, 2"
      }
    }
  ]
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Michael Mellink",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-08-01",
      "evidence_quote": "la pr\u00E9sente assembl\u00E9e a \u00E9t\u00E9 convoqu\u00E9e avec l\u0027ordre du jour suivant : - D\u00E9mission de Monsieur Michael Mellink en tant qu\u0027administrateur avec effet imm\u00E9diat;",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Charles Nelles",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-08-01",
      "evidence_quote": "Nomination de Monsieur Charles Nelles en tant qu\u0027administrateur avec effet imm\u00E9diat et pour une dur\u00E9e de 6 ans:",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": 6
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "decharge_granted",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Michael Mellink",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "La d\u00E9mission avec effet imm\u00E9diat de Monsieur Michael Mellink a \u00E9t\u00E9 accept\u00E9e;",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "decharge_granted",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Charles Nelles",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "La nomination, avec effet imm\u00E9diat, de Monsieur Charles Nelles pour une dur\u00E9e de 6 ans a \u00E9t\u00E9 accept\u00E9e.",
      "decharge_status": "granted",
      "mandate_duration": {
        "kind": "n_years",
        "value": 6
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Liege",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-09-16",
    "filing_date": "2025-08-01",
    "act_kind_objet": "Objet de l\u0027acte"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2025-07-02",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0540.870.218",
    "name_full": "AQUILON PHARMACEUTICALS",
    "legal_form": "SA",
    "_kbo_filled_from_list": true
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": "0473.951.403",
    "org_name": "JACQUES \u0026 ASSOCIES SRL",
    "person_name": null,
    "org_rep_person_name": "Julien JACQUES",
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "Proc\u00E8s-verbal de l\u0027AGO du 02/07/2025"
  ],
  "corrected_publication_numac": null
}

{
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Herstal",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2025-07-04",
    "filing_date": "2025-07-02",
    "act_kind_objet": "STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), CAPITAL, ACTIONS"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2025-07-02",
    "unanimous": null
  },
  "statute_change": {
    "kinds": [
      "translation",
      "coordination",
      "targeted_amendment"
    ],
    "scope": "full_restatement",
    "trigger": "capital_change_consequence",
    "language_after": null,
    "language_before": null
  },
  "bedrijfsrevisor": {
    "firm_kbo": null,
    "firm_name": "AXYLIUM AUDIT \u2013 LIEGE",
    "ibr_number": null,
    "individual_name": "David DEMONCEAU"
  },
  "subject_company": {
    "kbo": "0540.870.218",
    "name_full_after": "AQUILON PHARMACEUTICALS",
    "legal_form_after": "Soci\u00E9t\u00E9 anonyme",
    "name_full_before": "AQUILON PHARMACEUTICALS",
    "current_zetel_raw": "Rue du Bois St-Jean 15/1, 4102 Seraing",
    "legal_form_before": "Soci\u00E9t\u00E9 anonyme"
  },
  "special_mandates": [],
  "articles_modified": [
    {
      "summary": "Le capital est fix\u00E9 \u00E0 5.486.277,23 \u20AC et repr\u00E9sent\u00E9 par 262.674 actions sans d\u00E9signation de valeur nominale, dont 43.420 de classe A, 70.616 de classe B, 42.414 de classe C, 97.211 de classe D, et 9.013 de classe E.",
      "new_text": "Le capital est fix\u00E9 \u00E0 cinq millions quatre cent quatre-vingt-six mille deux cent septante-sept euros vingt-trois cents (5.486.277,23 \u20AC). Il est repr\u00E9sent\u00E9 par 262.674 actions avec droit de vote, sans d\u00E9signation de valeur nominale, repr\u00E9sentant chacune 1/262.674e de l\u2019avoir social, dont 43.420 actions de classe A, 70.616 actions de classe B, 42.414 actions de classe C, 97.211 actions de classe D, ",
      "change_kind": "amended",
      "article_title": null,
      "article_number": "5 \u00A71er"
    }
  ],
  "governance_change": null,
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Geoffrey GAUTHY",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations et les rapports",
    "la coordination des statuts"
  ],
  "shareholder_rights": null,
  "voorwerp_change_summary": null,
  "capital_structure_change": {
    "operations": [
      "capital_increase_kind",
      "share_class_creation"
    ],
    "split_ratio": null,
    "shares_after": 262674,
    "shares_before": 262674,
    "capital_after_eur": 5486277.23,
    "capital_before_eur": 4112455.8,
    "share_classes_after": [
      {
        "count": 7521,
        "label": "A",
        "rights_summary": "Droit de vote",
        "voting_per_share": 1.0
      },
      {
        "count": 7796,
        "label": "C",
        "rights_summary": "Droit de vote",
        "voting_per_share": 1.0
      },
      {
        "count": 24199,
        "label": "D",
        "rights_summary": "Droit de vote",
        "voting_per_share": 1.0
      }
    ]
  },
  "coordinated_text_lineage": null
}

{
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Herstal",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-05-22",
    "filing_date": "2025-05-20",
    "act_kind_objet": "STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), CAPITAL, ACTIONS"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2025-05-20",
    "unanimous": null
  },
  "statute_change": {
    "kinds": [
      "translation",
      "coordination",
      "targeted_amendment"
    ],
    "scope": "full_restatement",
    "trigger": "capital_change_consequence",
    "language_after": null,
    "language_before": null
  },
  "bedrijfsrevisor": {
    "firm_kbo": null,
    "firm_name": "AXYLIUM AUDIT \u2013 LIEGE",
    "ibr_number": null,
    "individual_name": "David DEMONCEAU"
  },
  "subject_company": {
    "kbo": "0540.870.218",
    "name_full_after": "AQUILON PHARMACEUTICALS",
    "legal_form_after": "Soci\u00E9t\u00E9 anonyme",
    "name_full_before": "AQUILON PHARMACEUTICALS",
    "current_zetel_raw": "Rue Porte de Lorette(VIS) 76 : 4600 Vis\u00E9",
    "legal_form_before": "Soci\u00E9t\u00E9 anonyme"
  },
  "special_mandates": [],
  "articles_modified": [
    {
      "summary": "The article defining the capital and share structure was replaced with new text reflecting the post-increase capital of \u20AC4,112,455.80 and the new share class distribution.",
      "new_text": "Le capital est fix\u00E9 \u00E0 quatre millions cent douze mille quatre cent cinquante-cinq euros quatre-vingt cents (4.112.455,80 \u20AC). Il est repr\u00E9sent\u00E9 par 223.158 actions avec droit de vote, sans d\u00E9signation de valeur nominale, repr\u00E9sentant chacune 1/222.593e de l\u2019avoir social, dont 35.899 actions de classe A, 70.616 actions de classe B, 34.618 actions de classe C, 73.012 actions de classe D, et 9.013 act",
      "change_kind": "amended",
      "article_title": null,
      "article_number": "5 \u00A7 1er"
    },
    {
      "summary": "The article defining the annual general meeting date was replaced with new text.",
      "new_text": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire se r\u00E9unit annuellement le dernier jeudi de juin \u00E0 seize heures.",
      "change_kind": "amended",
      "article_title": null,
      "article_number": "24 alin\u00E9a 1er"
    }
  ],
  "governance_change": null,
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Geoffrey GAUTHY",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations et les rapports",
    "la coordination des statuts"
  ],
  "shareholder_rights": {
    "quorum_rules_changed": false,
    "liquidation_preference_text": "*25333276*",
    "voorkeurrecht_rules_changed": true,
    "aandelenoverdracht_restrictions_changed": false
  },
  "voorwerp_change_summary": null,
  "capital_structure_change": {
    "operations": [
      "capital_increase_cash",
      "capital_increase_kind",
      "share_class_creation"
    ],
    "split_ratio": null,
    "shares_after": 223158,
    "shares_before": 206500,
    "capital_after_eur": 4112455.8,
    "capital_before_eur": 3646398.84,
    "share_classes_after": [
      {
        "count": 35899,
        "label": "A",
        "rights_summary": "droit de vote",
        "voting_per_share": 1.0
      },
      {
        "count": 70616,
        "label": "B",
        "rights_summary": "droit de vote",
        "voting_per_share": 1.0
      },
      {
        "count": 34618,
        "label": "C",
        "rights_summary": "droit de vote",
        "voting_per_share": 1.0
      },
      {
        "count": 73012,
        "label": "D",
        "rights_summary": "droit de vote",
        "voting_per_share": 1.0
      },
      {
        "count": 9013,
        "label": "E",
        "rights_summary": "droit de vote",
        "voting_per_share": 1.0
      }
    ]
  },
  "coordinated_text_lineage": null
}

{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Paul Maes",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": {
        "kbo": null,
        "name": "Maes PharmConsult Srl",
        "address": null,
        "country": null,
        "legal_form": "SRL"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": "2024-06-04",
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "6"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Gauthier Van Der Elst",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": {
        "kbo": null,
        "name": "Scale I",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "statutory": null,
      "compensated": null,
      "effective_date": "2024-06-04",
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "6"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Vis\u00E9",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-04-16",
    "filing_date": "2024-06-04",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2024-07-16",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0540.870.218",
    "name_full": "AQUILON PHARMACEUTICALS",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "_kbo_filled_from_list": true
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "SRL Jacques \u0026 Associ\u00E9s",
    "person_name": "Julien JACQUES",
    "org_rep_person_name": "Julien JACQUES",
    "person_role_at_subject": "mandataire"
  },
  "co_filed_documents": [
    "copie du Proc\u00E8s-verbal de I\u0027AGO du 16/07/2024",
    "procuration"
  ],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 2766104.65,
      "delta_eur": 249816.0,
      "before_eur": 2516288.65,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 8922,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 28.0
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 249816.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 3015920.65,
      "delta_eur": 249816.0,
      "before_eur": 2766104.65,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 8922,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 28.0
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 249816.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 3465910.84,
      "delta_eur": 449990.19,
      "before_eur": 3015920.65,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 16251,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 27.69
      },
      "decrease_purpose": null,
      "contribution_type": "natura",
      "paid_up_delta_eur": 449990.19,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Herstal",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-03-20",
    "filing_date": "2025-03-18",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2025-03-14",
    "unanimous": null,
    "under_authorized_capital": true,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": null,
    "firm_name": "AXYLIUM AUDIT \u2013 LIEGE",
    "ibr_number": null,
    "mission_type": "apport_nature",
    "individual_name": "David DEMONCEAU"
  },
  "subject_company": {
    "kbo": "0540.870.218",
    "name_full": "AQUILON PHARMACEUTICALS",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations et les rapports",
    "la coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 31446,
      "class_name": "A",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 59716,
      "class_name": "B",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 30149,
      "class_name": "C",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 61166,
      "class_name": "D",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 8655,
      "class_name": "E",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    }
  ]
}

{
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2024-12-23",
    "filing_date": "2024-12-19",
    "act_kind_objet": "CAPITAL, ACTIONS, STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS)"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2024-12-19",
    "unanimous": null
  },
  "statute_change": {
    "kinds": [
      "translation",
      "coordination",
      "targeted_amendment"
    ],
    "scope": "full_restatement",
    "trigger": "other",
    "language_after": null,
    "language_before": null
  },
  "bedrijfsrevisor": {
    "firm_kbo": null,
    "firm_name": "AXYLIUM AUDIT \u2013 LIEGE",
    "ibr_number": null,
    "individual_name": "DEMONCEAU David"
  },
  "subject_company": {
    "kbo": "0540.870.218",
    "name_full_after": "AQUILON PHARMACEUTICALS",
    "legal_form_after": "Soci\u00E9t\u00E9 anonyme",
    "name_full_before": "AQUILON PHARMACEUTICALS",
    "current_zetel_raw": "Rue Porte de Lorette(VIS) 76 : 4600 Vis\u00E9",
    "legal_form_before": "Soci\u00E9t\u00E9 anonyme"
  },
  "special_mandates": [],
  "articles_modified": [
    {
      "summary": "Le capital est fix\u00E9 \u00E0 2.516.288,65 \u20AC et repr\u00E9sent\u00E9 par 165.959 actions sans d\u00E9signation de valeur nominale, dont 5 classes (A \u00E0 E) jouissant des m\u00EAmes droits.",
      "new_text": "Le capital est fix\u00E9 \u00E0 deux millions cinq cent seize mille deux cent quatre-vingt-huit euros soixante-cinq cents (2.516.288,65 \u20AC). Il est repr\u00E9sent\u00E9 par 165.959 actions avec droit de vote, sans d\u00E9signation de valeur nominale, repr\u00E9sentant chacune 1/165.959e) de l\u2019avoir social, dont 27.876 actions de classe A, 43.465 actions de classe B, 29.792 actions de classe C, 56.171 actions de classe D, et 8.6",
      "change_kind": "amended",
      "article_title": null,
      "article_number": "5 \u00A71er"
    }
  ],
  "governance_change": null,
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Geoffrey GAUTHY",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations et les rapports",
    "la coordination des statuts"
  ],
  "shareholder_rights": null,
  "voorwerp_change_summary": null,
  "capital_structure_change": {
    "operations": [
      "capital_increase_kind",
      "share_class_creation"
    ],
    "split_ratio": null,
    "shares_after": 165959,
    "shares_before": 165959,
    "capital_after_eur": 2516288.65,
    "capital_before_eur": 2619395.19,
    "share_classes_after": [
      {
        "count": 27876,
        "label": "A",
        "rights_summary": "droit de vote",
        "voting_per_share": 1.0
      },
      {
        "count": 43465,
        "label": "B",
        "rights_summary": "droit de vote",
        "voting_per_share": 1.0
      },
      {
        "count": 29792,
        "label": "C",
        "rights_summary": "droit de vote",
        "voting_per_share": 1.0
      },
      {
        "count": 56171,
        "label": "D",
        "rights_summary": "droit de vote",
        "voting_per_share": 1.0
      },
      {
        "count": 8655,
        "label": "E",
        "rights_summary": "droit de vote",
        "voting_per_share": 1.0
      }
    ]
  },
  "coordinated_text_lineage": null
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 3381395.19,
      "delta_eur": 348278.08,
      "before_eur": 3033117.11,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 7546,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 46.154
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": 348278.08,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_decrease",
      "after_eur": 2619395.19,
      "delta_eur": -762000.0,
      "before_eur": 3381395.19,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": "loss_absorption",
      "contribution_type": "kapitalisering_reserves",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-11-14",
    "filing_date": "2023-11-10",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2023-11-09",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": null,
    "firm_name": "AXYLIUM AUDIT \u2013 LIEGE",
    "ibr_number": null,
    "mission_type": "apport_nature",
    "individual_name": "DEMONCEAU David"
  },
  "subject_company": {
    "kbo": "0540.870.218",
    "name_full": "AQUILON PHARMACEUTICALS",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations et les rapports",
    "la coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 26924,
      "class_name": "A",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 43465,
      "class_name": "B",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 28335,
      "class_name": "C",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 51064,
      "class_name": "D",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 8655,
      "class_name": "E",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    }
  ]
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "JEANMART Patrick",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "end_of_term",
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide de mettre un terme aux fonctions d\u2019administrateur de : \u00B7 Monsieur JEANMART Patrick",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "DE GHELDERE Joseph",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "end_of_term",
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide de mettre un terme aux fonctions d\u2019administrateur de : \u00B7 Monsieur DE GHELDERE Joseph",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "STREEL Micheline",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "end_of_term",
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "SAMBRINVEST SPIN-OFF/SPIN-OUT",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide de mettre un terme aux fonctions d\u2019administrateur de : \u00B7 La soci\u00E9t\u00E9 \u00AB SAMBRINVEST SPIN-OFF/SPIN-OUT \u00BB dont le repr\u00E9sentant permanent est Madame STREEL Micheline",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "BENAMEUR Hassan",
        "address": "69003 Lyon (France), rue Pierre Bonnaud, 61",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": false,
      "effective_date": null,
      "evidence_quote": "L\u2019assembl\u00E9e appelle aux fonctions d\u2019administrateurs : \u00B7 Monsieur BENAMEUR Hassan, domicili\u00E9 \u00E0 69003 Lyon (France), rue Pierre Bonnaud, 61, comme administrateur ind\u00E9pendant",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "6"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "MELLINK Mich\u00E4el",
        "address": "Hilversumseweg 14a 1251EX Laren (Pays-Bas)",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": false,
      "effective_date": null,
      "evidence_quote": "L\u2019assembl\u00E9e appelle aux fonctions d\u2019administrateurs : \u00B7 Monsieur MELLINK Mich\u00E4el, domicili\u00E9 \u00E0 Hilversumseweg 14a 1251EX Laren (Pays-Bas), comme administrateur de classe B",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "6"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "MANOR Moshe",
        "address": "Hacarmek st, Ramat Hasharon, 4723007 Israel",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": false,
      "effective_date": null,
      "evidence_quote": "L\u2019assembl\u00E9e appelle aux fonctions d\u2019administrateurs : \u00B7 Monsieur MANOR Moshe, domicili\u00E9 \u00E0 Hacarmek st, Ramat Hasharon, 4723007 Israel, comme administrateur de classe D",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "6"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "VAN DER ELST Gauthier",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Suite \u00E0 la r\u00E9solution qui pr\u00E9c\u00E8de, l\u2019assembl\u00E9e g\u00E9n\u00E9rale constate que Monsieur VAN DER ELST Gauthier est un administrateur des classes C et E.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "David DEMONCEAU",
        "address": null,
        "birth_date": null,
        "profession": "r\u00E9viseur d\u2019entreprises",
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "SAINTENOY, COMHAIRE \u0026 CO",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "du rapport \u00E9tabli par la soci\u00E9t\u00E9 \u00AB SAINTENOY, COMHAIRE \u0026 CO \u00BB, repr\u00E9sent\u00E9e par Monsieur David DEMONCEAU, r\u00E9viseur d\u2019entreprises, en date du 27 janvier 2023",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "correction",
      "role": null,
      "person": null,
      "reason": null,
      "subkind": "rectification",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": "Jean-Michel GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2023-02-17",
    "filing_date": "2023-02-15",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "buitengewone_algemene_vergadering",
      "date": "2023-02-13",
      "unanimous": null
    },
    {
      "body": "algemene_vergadering",
      "date": "2018-11-30",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0540.870.218",
    "name_full": "AQUILON PHARMACEUTICALS",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Jean-Michel GAUTHY",
    "org_rep_person_name": null,
    "person_role_at_subject": "notaire"
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations, le rapport du CA et le rapport du r\u00E9viseur",
    "la coordination des statuts"
  ],
  "corrected_publication_numac": null
}